From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.
10.1097/CM9.0000000000000981
- Author:
Kenneth I ZHENG
1
;
Jian-Gao FAN
2
;
Jun-Ping SHI
3
;
Vincent Wai-Sun WONG
4
;
Mohammed ESLAM
5
;
Jacob GEORGE
5
;
Ming-Hua ZHENG
1
Author Information
1. Department of Hepatology, MAFLD Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 25000, China.
2. Department of Gastroenterology, Center for Fatty Liver, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai 200065, China.
3. Department of Liver Diseases, Hangzhou Normal University Affiliated Hospital, Hangzhou, Zhejiang 311121, China.
4. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 999077, China.
5. Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney 2145, Australia.
- Publication Type:Journal Article
- From:
Chinese Medical Journal
2020;133(19):2271-2273
- CountryChina
- Language:English